Literature DB >> 17557962

Dexamethasone-induced posterior reversible encephalopathy syndrome.

William Irvin1, Gigi MacDonald, J Keith Smith, William Y Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17557962     DOI： 10.1200/JCO.2007.10.9991

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  14 in total

1.  Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy.

Authors:  Stephanie H Hernandez; Sage W Wiener; Silas W Smith
Journal:  J Med Toxicol       Date:  2010-06

Review 2.  Reversible posterior leukoencephalopathy syndrome in cancer.

Authors:  Christopher Vaughn; Louann Zhang; David Schiff
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

3.  Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient.

Authors:  Ola Abbas; Ali Shamseddin; Sally Temraz; Ali Haydar
Journal:  BMJ Case Rep       Date:  2013-02-21

4.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.

Authors:  Neal S Parikh; Andrew D Schweitzer; Robert J Young; Ashley E Giambrone; John Lyo; Sasan Karimi; Anna Knobel; Ajay Gupta; Babak B Navi
Journal:  J Neurol Sci       Date:  2017-06-29       Impact factor: 3.181

5.  Age and gender may affect posterior reversible encephalopathy syndrome in renal disease.

Authors:  Akio Yamada; Norishi Ueda
Journal:  Pediatr Nephrol       Date:  2011-08-07       Impact factor: 3.714

Review 6.  Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.

Authors:  Joan How; Margaret Blattner; Susan Fowler; Andrea Wang-Gillam; Suzanne E Schindler
Journal:  Neurologist       Date:  2016-11       Impact factor: 1.398

7.  Posterior reversible encephalopathy syndrome induced by enzalutamide in a patient with castration-resistant prostate cancer.

Authors:  Daniel J Crona; Young E Whang
Journal:  Invest New Drugs       Date:  2014-12-03       Impact factor: 3.850

Review 8.  [Headache and hypertension. Myth and evidence].

Authors:  T Liman; E Siebert; M Endres
Journal:  Nervenarzt       Date:  2010-08       Impact factor: 1.214

9.  Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Authors:  Stephane Legriel; Fabrice Bruneel; Odile Spreux-Varoquaux; Aurelie Birenbaum; Marie Laure Chadenat; François Mignon; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

10.  A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome.

Authors:  Eun Jin Kwon; Se Won Kim; Kwang Ki Kim; Hyung Suk Seo; Do Yeun Kim
Journal:  Cancer Res Treat       Date:  2009-03-31       Impact factor: 4.679
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.